Home > Personal Investment Vitae
Location: United States
Gender: Female
Asset investment style: Quantitative fundamental analysis
Market capitalization:
$8,096,745talentsVirtual portfolio value:
$5,202,602talentsNet overall return per annum:
20.21%AYA current rank order:
#13Asset investment philosophy:
Daisy Harvey trades U.S. stocks with the top #76 to #500 positive alpha signals.
Top 10 profitable stock transactions since January 2020Strategy
| Symbol | Company | Buy | Sell | Share Volume | Return (%) | Profit ($) |
|---|---|---|---|---|---|---|
| VATE | INNOVATE Corp. Common Stock | $0.53 | $4.14 | 56,283 | +681.13% | $203,182 |
| RMBL | RumbleOn Inc. Class B Common Stock | $0.36 | $7.95 | 24,133 | +2,108.33% | $183,169 |
| LGVN | Longeveron Inc. Class A Common Stock | $3.45 | $26.25 | 2,347 | +660.87% | $53,512 |
| AXSM | Axsome Therapeutics Inc. Common Stock | $4.60 | $31.75 | 1,335 | +590.22% | $36,245 |
| LSCC | Lattice Semiconductor Corporation Common Stock | $6.97 | $48.04 | 881 | +589.24% | $36,183 |
| SQ | Block Inc. Class A Common Stock | $14.50 | $99.54 | 423 | +586.48% | $35,972 |
| FIVN | Five9 Inc. Common Stock | $16.31 | $110.10 | 376 | +575.05% | $35,265 |
| TRNS | Transcat Inc. Common Stock | $11.35 | $73.00 | 541 | +543.17% | $33,353 |
| GLOB | Globant S.A. Common Shares | $34.57 | $215.99 | 177 | +524.79% | $32,111 |
| HZNP | Horizon Therapeutics Public Limited Company Ordinary Shares | $16.41 | $98.56 | 374 | +500.61% | $30,724 |
| Sum | $679,716 |
Top 10 current stock portfolio positions as of December 2025Strategy
| Symbol | Company | Price | Position | Capitalization |
|---|---|---|---|---|
| DHIL | Diamond Hill Investment Group Inc. Class A Common Stock | $169.68 | 180 | $30,542 |
| DRUG | Bright Minds Biosciences Inc. Common Stock | $93.99 | 304 | $28,572 |
| AEO | American Eagle Outfitters Inc. Common Stock | $27.36 | 1,043 | $28,536 |
| RKLB | Rocket Lab Corporation Common Stock | $55.49 | 505 | $28,022 |
| MDB | MongoDB Inc. Class A Common Stock | $421.50 | 64 | $26,976 |
| TCI | Transcontinental Realty Investors Inc. Common Stock | $58.00 | 462 | $26,796 |
| SOC | Sable Offshore Corp. Common Stock | $5.43 | 4,870 | $26,444 |
| NVCT | Nuvectis Pharma Inc. Common Stock | $7.69 | 3,410 | $26,222 |
| ARWR | Arrowhead Pharmaceuticals Inc. Common Stock | $64.66 | 403 | $26,057 |
| MAMA | Mama's Creations Inc. Common Stock | $13.77 | 1,880 | $25,887 |
| Sum | $274,054 |
Top 20 investors
Top 20 influencers
| #1 - #5 | #6 - #10 | #11 - #15 | #15 - #20 |
|---|---|---|---|
| @Chanel Holden | |||
| @Andy Yeh Alpha | |||
Top 20 followers
| #1 - #5 | #6 - #10 | #11 - #15 | #15 - #20 |
|---|---|---|---|
| @Bob Hessonwitz | @Vincent Bonsai | @Jack hsu | @Apple |
| @Will | @Darren | @AJ Yeh | @ZimboDave |
| @Luminoalgo | @Sandra Martinazzison | @MRCASH1991 | @Bloom789 |
| @Duke | @Mo | @Amy | @Andy Cheung |
| @TechBull22 | @Ru-Ting Yeh | @Syl_will | @George |
2019-01-10 17:31:00 Thursday ET
The recent Bristol-Myers Squibb acquisition of American Celgene is the $90 billion biggest biotech deal in history. The resultant biopharma goliath would be
2025-09-28 10:10:51 Sunday ET
Stock Synopsis: With a new Python program, we use, adapt, apply, and leverage each of the mainstream Gemini Gen AI models to conduct this comprehensive fund
2022-10-25 11:31:00 Tuesday ET
Corporate investment insights from mergers and acquisitions Relative market misvaluation between the bidder and target firms drives most waves of mergers
2019-08-31 14:39:00 Saturday ET
AYA Analytica finbuzz podcast channel on YouTube August 2019 In this podcast, we discuss several topical issues as of August 2019: (1) Warren B
2021-05-20 10:30:00 Thursday ET
Artificial intelligence, 5G, and virtual reality can help transform global trade, finance, and technology. Core trade technological advances and disruptive
2019-09-01 10:31:00 Sunday ET
Most artificial intelligence applications cannot figure out the intricate nuances of natural language and facial recognition. These intricate nuances repres